Alvotech (ALVO) vs BioCryst Pharmaceuticals, Inc. (BCRX)
- Alvotech ALVO 5.00 −5.84%
- BioCryst Pharmaceuticals, Inc. BCRX 7.79 −2.87%
Alvotech and BioCryst Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech and BioCryst Pharmaceuticals, Inc. are of similar size ($2.1B and $2.1B). Alvotech grew revenue faster over the last twelve months: 364.3% against 68.7%. BioCryst Pharmaceuticals, Inc. has the higher net margin (−40.9% vs −101.1%) and the lower return on invested capital (−610.6% vs 0.00%). Across the 16 metrics below, BioCryst Pharmaceuticals, Inc. leads on 12 and Alvotech on 4.
Valuation
Profitability
| Metric | ALVO | BCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 97.78% | 53.94% |
| Operating margin | (42.43%) | (33.29%) | 0.00% |
| Net margin | (101.05%) | (40.90%) | 0.00% |
| Free cash flow margin | 0.00% | 39.75% | 0.00% |
| Return on equity | 0.00% | 87.84% | (0.40%) |
| Return on assets | 0.00% | (75.79%) | (3.32%) |
| Return on invested capital | 0.00% | (610.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack